Pfizer made one thing clear this week: It's officially back in the obesity race.

The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...

Doctors, patients and researchers are at the very beginning of understanding how the new class of obesity drugs interact with ...

A team of scientists has uncovered a critical mechanism that could pave the way for safer and more effective obesity ...

Researchers have quantified the role of obesity in common long-term conditions, showing for the first time the effect of ...

Over the next decade, obesity rates across the nation could surge to close to half of U.S. adults, a new study published in ...

Corbus Pharmaceuticals maintains a 'Hold' rating as it advances CRB-701 for HNSCC and CRB-913 for obesity. Click here to read ...

The long-held Wall Street expectation that the global market for obesity drugs would reach $150 billion in the next decade is ...

Obesity is a common risk factor for various long-term conditions (LTCs), according to a February study published in Nature Communications.

Researchers reviewed the body mass index of over 11 million Americans.

Obesity is contributing to a record proportion of deaths among pregnant women, the Royal College of Physicians has warned.

Sen. Ana Maria Rodriguez and Rep. Susan L. Valdés were joined Thursday by Dr. Joey Jarrard of Tallahassee Memorial Healthcare ...